Potential of MR spectroscopy for assessment of glioma grading

J 2013

Potential of MR spectroscopy for assessment of glioma grading

BULIK, Martin, Radim JANČÁLEK, Jiří VANÍČEK, Antonín ŠKOCH, Marek MECHL et. al.

Basic information

Original name

Potential of MR spectroscopy for assessment of glioma grading

Authors

BULIK, Martin (203 Czech Republic, guarantor, belonging to the institution), Radim JANČÁLEK (203 Czech Republic, belonging to the institution), Jiří VANÍČEK (203 Czech Republic, belonging to the institution), Antonín ŠKOCH (203 Czech Republic) and Marek MECHL (203 Czech Republic, belonging to the institution)

Edition

Clinical Neurology and Neurosurgery, Amsterdam, Elsevier, 2013, 0303-8467

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.248

RIV identification code

RIV/00216224:14110/13:00067698

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.clineuro.2012.11.002

UT WoS

000314447500005

Keywords in English

Magnetic resonance spectroscopy; Metabolites; Glioma; Grade

Abstract

V originále

Magnetic resonance spectroscopy (MRS) is an imaging diagnostic method based that allows non-invasive measurement of metabolites in tissues. There are a number of metabolites that can be identified by standard brain proton MRS but only a few of them has a clinical significance in diagnosis of gliomas including N-acetylaspartate, choline, creatine, myo-inositol, lactate, and lipids. Results: Low-grade gliomas are generally characterized by a relatively high concentration of Nacetylaspartate, low level of choline and absence of lactate and lipids. The increase in creatine concentration indicates low-grade gliomas with earlier progression and malignant transformation. Progression in grade of a glioma is reflected in the progressive decrease in the N-acetylaspartate and myo-inositol levels on the one hand and elevation in choline level up to grade III on the other. Malignant transformation of the glial tumors is also accompanied by the presence of lactate and lipids in MR spectra of grade III but mainly grade IV gliomas. It follows that MRS is a helpful method for detection of glioma regions with aggressive growth or upgrading due to favorable correlation of the choline and N-acetylaspartate levels with histopathological proliferation index Ki-67. Thus, magnetic resonance spectroscopy is also a suitable method for the targeting of brain biopsies. Conclusions: Gliomas of each grade have some specific MRS features that can be used for improvement of the diagnostic value of conventional magnetic resonance imaging in non-invasive assessment of glioma grade.

Citovat

BULIK, Martin, Radim JANČÁLEK, Jiří VANÍČEK, Antonín ŠKOCH and Marek MECHL. Potential of MR spectroscopy for assessment of glioma grading. Clinical Neurology and Neurosurgery. Amsterdam: Elsevier, 2013, vol. 115, No 2, p. 146-153. ISSN 0303-8467. Available from: https://dx.doi.org/10.1016/j.clineuro.2012.11.002.

@article{1084655,
   author = {Bulik, Martin and Jančálek, Radim and Vaníček, Jiří and Škoch, Antonín and Mechl, Marek},
   article_location = {Amsterdam},
   article_number = {2},
   doi = {http://dx.doi.org/10.1016/j.clineuro.2012.11.002},
   keywords = {Magnetic resonance spectroscopy; Metabolites; Glioma; Grade},
   language = {eng},
   issn = {0303-8467},
   journal = {Clinical Neurology and Neurosurgery},
   title = {Potential of MR spectroscopy for assessment of glioma grading},
   volume = {115},
   year = {2013}
}

TY  - JOUR
ID  - 1084655
AU  - Bulik, Martin - Jančálek, Radim - Vaníček, Jiří - Škoch, Antonín - Mechl, Marek
PY  - 2013
TI  - Potential of MR spectroscopy for assessment of glioma grading
JF  - Clinical Neurology and Neurosurgery
VL  - 115
IS  - 2
SP  - 146-153
EP  - 146-153
PB  - Elsevier
SN  - 03038467
KW  - Magnetic resonance spectroscopy
KW  - Metabolites
KW  - Glioma
KW  - Grade
N2  - Magnetic resonance spectroscopy (MRS) is an imaging diagnostic method based that allows non-invasive measurement of metabolites in tissues. There are a number of metabolites that can be identified by standard brain proton MRS but only a few of them has a clinical significance in diagnosis of gliomas including N-acetylaspartate, choline, creatine, myo-inositol, lactate, and lipids. Results: Low-grade gliomas are generally characterized by a relatively high concentration of Nacetylaspartate, low level of choline and absence of lactate and lipids. The increase in creatine concentration indicates low-grade gliomas with earlier progression and malignant transformation. Progression in grade of a glioma is reflected in the progressive decrease in the N-acetylaspartate and myo-inositol levels on the one hand and elevation in choline level up to grade III on the other. Malignant transformation of the glial tumors is also accompanied by the presence of lactate and lipids in MR spectra of grade III but mainly grade IV gliomas. It follows that MRS is a helpful method for detection of glioma regions with aggressive growth or upgrading due to favorable correlation of the choline and N-acetylaspartate levels with histopathological proliferation index Ki-67. Thus, magnetic resonance spectroscopy is also a suitable method for the targeting of brain biopsies. Conclusions: Gliomas of each grade have some specific MRS features that can be used for improvement of the diagnostic value of conventional magnetic resonance imaging in non-invasive assessment of glioma grade.
ER  -

BULIK, Martin, Radim JANČÁLEK, Jiří VANÍČEK, Antonín ŠKOCH and Marek MECHL. Potential of MR spectroscopy for assessment of glioma grading. \textit{Clinical Neurology and Neurosurgery}. Amsterdam: Elsevier, 2013, vol.~115, No~2, p.~146-153. ISSN~0303-8467. Available from: https://dx.doi.org/10.1016/j.clineuro.2012.11.002.

Detailed Information on Publication Record